A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy
Clinical trial NCT05958407 · COMPLETED
Trial details
- NCT number
- NCT05958407
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-28
- Primary completion
- 2025-05-05
- Enrollment
- 235
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.